Answers are grounded in this paper and cite their sources.
Here, we discussed mechanisms of CRPC development and summarized the overall prevalence of CRPC subtypes; interestingly, AR low/negative CRPC represented a considerable proportion of diagnoses. Because these subtypes cannot be effectively treated with AR-targeted therapeutics, a better understanding of AR low/negative subtypes could lead to better treatment strategies and increased survival.
No takes yet. Share an insight, caveat, or question.
Vellky et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: